Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/522
Title: Stand-alone minimally invasive lateral lumbar interbody fusion: multicenter clinical outcomes.
Epworth Authors: Malham, Gregory
Other Authors: Ahmadian, Amir
Bach, Konrad
Bolinger, Bryan
Okonkwo, David
Kanter, Adam
Uribe, Juan
Keywords: Neurosciences Clinical Institute, Epworth HealthCare, Victoria, Australia
Neurologic Degenerative Diseases
Degenerative Diseases, Neurologic
Scoliosis
Interbody fusion
Minimally Invasive Surgical Procedures
Procedures, Minimally Invasive Surgical
Surgical Procedures, Minimally Invasive
Spondylolisthesis
Deformities
Spinal Fusion
Quality of Life
QoL
MIS-LIF
Degenerative Disc Disease
Spondylolisthesis
Adult Degenerative Scoliosis
Visula Analog Scale
VAS
Oswestry Disability Index
ODI
Issue Date: Apr-2015
Publisher: Elsevier
Citation: Journal of Clinical Neuroscience. 2015 Apr;22(4):740-6.
Abstract: Stand-alone minimally invasive lateral transpsoas inter-body fusion (MIS-LIF), without posterior instrumentation, is feasible because the technique does not necessitate the disruption of the stabilizing elements. The objectives of this study are to evaluate the efficacy and clinical outcomes of patients who underwent stand-alone lateral inter-body fusion. A multi-center chart review was conducted to identify patients who underwent stand-alone MIS-LIF between 2008 and 2012. Patients were classified by spinal pathology (degenerative disc disease [DDD], spondylolisthesis [SL] and adult degenerative scoliosis [ADS]). Routine clinical follow-up was scheduled at 3, 6, and12 months. Outcome measures included hospital length of stay, fusion rates, neurologic complications, integrity of construct and clinical outcome questionnaires (Visual Analog Scale [VAS] and Oswestry Disability Index [ODI]). A total of 59 patients met the inclusion criteria. The average age was 60 years (range 31-86 years). Spinal pathologies treated were DDD in 37 (63%), SL in four (7%) and ADS in 18 (30%) patients. Fusion rate was 93% of patients (95% of levels) at 12 months. Two patients required re-operation. Mean hospital stay and follow-up were 3.3days (range 1-10) and 14.6 months, respectively. The mean preoperative VAS and ODI were 69.1 and 51.8, respectively. VAS improved to 37.8 (p<0.0005). ODI improved to 31.8 (p<0.0005). Seventy percent of patients had grade 0 subsidence while 30% had grade I and grade II subsidence. Stand-alone MIS-LIF is viable option in a carefully selected patient population for both single and multilevel disease and shows significant improvement in health related quality of life.
URI: http://hdl.handle.net/11434/522
DOI: 10.1016/j.jocn.2014.08.036
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/25684343
ISSN: 0967-5868
1532-2653
Journal Title: Journal of Clinical Neuroscience
Type: Journal Article
Affiliated Organisations: Department of Neurosurgery, University of Pittsburgh, Pittsburg, PA, USA.
Department of Neurosurgery, University of South Florida, University of South Florida Health, Tampa, Florida, USA.
Type of Clinical Study or Trial: Review
Appears in Collections:Neurosciences
Musculoskeletal

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.